ASH News Daily 2017 - Issue 3 - C-9

Monday, December 11, 2017

ASH News Daily

Page C-9
®

Exhibitor List
«« From Page C-8

Rigel Pharmaceuticals ................................... 2705
Roswell Park Cancer Institute ...................... 2045
S-T
Sandoz, A Novartis Company ........................1902
Sanofi Genzyme.............................................. 1340
Sanofi Genzyme.............................................. 1541
Sarah Cannon Research Institute ..................... 39
Save One Life, Inc........................................... 1662
Seattle Cancer Care Alliance ......................... 1940
Seattle Children's Hospital ........................... 1946
Seattle Genetics ............................................... 1301
Shands Teaching Hospital and Clinics, Inc. 1746
Shire.................................................................. 2247
Shwachman-Diamond Syndrome
Foundation (SDSF) ...................................... 2050
SITC .................................................................. 1948
SkylineDx ........................................................ 2047
SoutheastHEALTH ........................................ 1660
Spectrum Pharmaceuticals, Inc. ..................... 423
Springer Healthcare ......................................... 409
Springer Nature .................................................. 49
St. Baldrick's Foundation .............................. 1750
STEMCELL Technologies, Inc. ....................... 941
StemExpress, LLC .......................................... 2952
Stemline Therapeutics ................................... 3122
Stemline Therapeutics ................................... 3143
Studio ER Congressi s.r.l. .................................611
Sunesis Pharmaceuticals, Inc. ....................... 2413
Synthego .......................................................... 2153
Takeda Oncology............................................ 2014

Takeda Oncology............................................ 2768
Takeda Oncology............................................ 3005
Techcyte, Inc. ..................................................... 504
Tecnofarma S.A................................................. 923
Tempus .............................................................. 408
TerSera Therapeutics ....................................... 313
TESARO........................................................... 2417
Teva Oncology ................................................ 1619
TG Therapeutics, Inc........................................ 905
The Aflac Cancer Center at
Children's Healthcare of Atlanta .............. 1852
The Binding Site, Inc. ..................................... 1833
The Blood and Marrow Transplant
Program at Northside Hospital..................... 43
The Guider Group .......................................... 2601
The JAMA Network ......................................... 608
The Japanese Society of Hematology .......... 1648
The Leukemia & Lymphoma Society .......... 1950
The Lynx Group ............................................. 1503
The Mastocytosis Society .............................. 1951
Tolero Pharmaceuticals, Inc. ........................... 503
Turkish Society of Hematology .................... 1841
U-V-W
UF Health Cancer Center - University
of Florida ...................................................... 1748
uniQure, Inc. ................................................... 2600
University of Chicago
Comprehensive Cancer Center ................. 2142
UT MD Anderson Cancer Center ................ 1507
Verastem .......................................................... 3043
Veristat ............................................................. 3247
Waldenstrom's Macroblobulinemia
Foundation ................................................... 1754

Winship Cancer Institute of
Emory University ........................................ 2053
WizSolution Research .................................... 1549
Wolters Kluwer ............................................... 1312
World Health Organization Press .................. 404
World Myeloma Forum ................................... 513
WVU Medicine ............................................... 1561
- As of November 9, 2017

Save the Date!

60th ASH Annual Meeting
and Exposition
®

Save the Date!
San Diego, California * December 1-4, 2018

Connect with the world of hematology at the premier event of the year!

www.hematology.org/annualmeeting

60th ASH® Annual
Meeting and Exposition
San Diego, California
December 1-4, 2018

...and we're exploring multiple
immunotherapies to fight them.
We are shaping the future of immuno-oncology by developing innovative
therapies that target multiple immune cell types for the treatment of
hematologic malignancies and solid tumors.
Please visit us at our booth or at www.researchoncology.com to learn
more about our immuno-oncology program.

Immunology Is In Our Blood



Table of Contents for the Digital Edition of ASH News Daily 2017 - Issue 3

ASH News Daily 2017 - Issue 3 - A-1
ASH News Daily 2017 - Issue 3 - A-2
ASH News Daily 2017 - Issue 3 - A-3
ASH News Daily 2017 - Issue 3 - A-4
ASH News Daily 2017 - Issue 3 - A-5
ASH News Daily 2017 - Issue 3 - A-6
ASH News Daily 2017 - Issue 3 - A-7
ASH News Daily 2017 - Issue 3 - A-8
ASH News Daily 2017 - Issue 3 - A-9
ASH News Daily 2017 - Issue 3 - A-10
ASH News Daily 2017 - Issue 3 - A-11
ASH News Daily 2017 - Issue 3 - A-12
ASH News Daily 2017 - Issue 3 - A-13
ASH News Daily 2017 - Issue 3 - A-14
ASH News Daily 2017 - Issue 3 - A-15
ASH News Daily 2017 - Issue 3 - A-16
ASH News Daily 2017 - Issue 3 - A-17
ASH News Daily 2017 - Issue 3 - A-18
ASH News Daily 2017 - Issue 3 - A-19
ASH News Daily 2017 - Issue 3 - A-20
ASH News Daily 2017 - Issue 3 - A-21
ASH News Daily 2017 - Issue 3 - A-22
ASH News Daily 2017 - Issue 3 - A-23
ASH News Daily 2017 - Issue 3 - A-24
ASH News Daily 2017 - Issue 3 - A-25
ASH News Daily 2017 - Issue 3 - A-26
ASH News Daily 2017 - Issue 3 - A-27
ASH News Daily 2017 - Issue 3 - A-28
ASH News Daily 2017 - Issue 3 - B-1
ASH News Daily 2017 - Issue 3 - B-2
ASH News Daily 2017 - Issue 3 - B-3
ASH News Daily 2017 - Issue 3 - B-4
ASH News Daily 2017 - Issue 3 - B-5
ASH News Daily 2017 - Issue 3 - B-6
ASH News Daily 2017 - Issue 3 - B-7
ASH News Daily 2017 - Issue 3 - B-8
ASH News Daily 2017 - Issue 3 - B-9
ASH News Daily 2017 - Issue 3 - B-10
ASH News Daily 2017 - Issue 3 - B-11
ASH News Daily 2017 - Issue 3 - B-12
ASH News Daily 2017 - Issue 3 - B-13
ASH News Daily 2017 - Issue 3 - B-14
ASH News Daily 2017 - Issue 3 - B-15
ASH News Daily 2017 - Issue 3 - B-16
ASH News Daily 2017 - Issue 3 - B-17
ASH News Daily 2017 - Issue 3 - B-18
ASH News Daily 2017 - Issue 3 - B-19
ASH News Daily 2017 - Issue 3 - B-20
ASH News Daily 2017 - Issue 3 - B-21
ASH News Daily 2017 - Issue 3 - B-22
ASH News Daily 2017 - Issue 3 - B-23
ASH News Daily 2017 - Issue 3 - B-24
ASH News Daily 2017 - Issue 3 - B-25
ASH News Daily 2017 - Issue 3 - B-26
ASH News Daily 2017 - Issue 3 - B-27
ASH News Daily 2017 - Issue 3 - B-30
ASH News Daily 2017 - Issue 3 - B-31
ASH News Daily 2017 - Issue 3 - B-32
ASH News Daily 2017 - Issue 3 - B-33
ASH News Daily 2017 - Issue 3 - B-34
ASH News Daily 2017 - Issue 3 - B-35
ASH News Daily 2017 - Issue 3 - B-36
ASH News Daily 2017 - Issue 3 - B-37
ASH News Daily 2017 - Issue 3 - B-38
ASH News Daily 2017 - Issue 3 - B-39
ASH News Daily 2017 - Issue 3 - B-40
ASH News Daily 2017 - Issue 3 - B-41
ASH News Daily 2017 - Issue 3 - B-42
ASH News Daily 2017 - Issue 3 - B-43
ASH News Daily 2017 - Issue 3 - B-44
ASH News Daily 2017 - Issue 3 - B-45
ASH News Daily 2017 - Issue 3 - B-46
ASH News Daily 2017 - Issue 3 - B-47
ASH News Daily 2017 - Issue 3 - B-48
ASH News Daily 2017 - Issue 3 - B-49
ASH News Daily 2017 - Issue 3 - B-50
ASH News Daily 2017 - Issue 3 - B-51
ASH News Daily 2017 - Issue 3 - B-52
ASH News Daily 2017 - Issue 3 - B-53
ASH News Daily 2017 - Issue 3 - B-54
ASH News Daily 2017 - Issue 3 - B-55
ASH News Daily 2017 - Issue 3 - B-56
ASH News Daily 2017 - Issue 3 - C-1
ASH News Daily 2017 - Issue 3 - C-2
ASH News Daily 2017 - Issue 3 - C-3
ASH News Daily 2017 - Issue 3 - C-4
ASH News Daily 2017 - Issue 3 - C-5
ASH News Daily 2017 - Issue 3 - C-6
ASH News Daily 2017 - Issue 3 - C-7
ASH News Daily 2017 - Issue 3 - C-8
ASH News Daily 2017 - Issue 3 - C-9
ASH News Daily 2017 - Issue 3 - C-10
ASH News Daily 2017 - Issue 3 - C-11
ASH News Daily 2017 - Issue 3 - C-12
ASH News Daily 2017 - Issue 3 - C-13
ASH News Daily 2017 - Issue 3 - C-14
ASH News Daily 2017 - Issue 3 - C-15
ASH News Daily 2017 - Issue 3 - C-16
ASH News Daily 2017 - Issue 3 - C-17
ASH News Daily 2017 - Issue 3 - C-18
ASH News Daily 2017 - Issue 3 - C-19
ASH News Daily 2017 - Issue 3 - C-20
ASH News Daily 2017 - Issue 3 - C-21
ASH News Daily 2017 - Issue 3 - C-22
ASH News Daily 2017 - Issue 3 - C-23
ASH News Daily 2017 - Issue 3 - C-24
ASH News Daily 2017 - Issue 3 - C-25
ASH News Daily 2017 - Issue 3 - C-26
ASH News Daily 2017 - Issue 3 - C-27
ASH News Daily 2017 - Issue 3 - C-28
ASH News Daily 2017 - Issue 3 - C-29
ASH News Daily 2017 - Issue 3 - C-30
ASH News Daily 2017 - Issue 3 - C-31
ASH News Daily 2017 - Issue 3 - C-32
https://www.nxtbookmedia.com